System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Edward A Levine is an expert in Surgery at Atrium Health Wake Forest Baptist (United States). As of October 2026, ScienceLeadR ranks Edward A Levine in the top 1% of experts worldwide for Abdominal Neoplasms, Peritoneal Neoplasms and Cecal Diseases. Edward A Levine has authored 544 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 1 of them ongoing. SLR score: 1,481 (community average: 125). How the SLR is computed.

LeadR Profile

Edward A Levine Atrium Health Wake Forest Baptist United States
1 481 ScienceLeadR Reputation 1481

Unlock

Register Login
Network Map

Surgery

Subspecialties: Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1992 - 2026
Source: PubMed

Wake Forest University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 544

Citations

Citations: 23 719 1st author: 28 Last author: 151 Unique author: 13

Main journals

Ann Surg Oncol 127
Am Surg 64
J Surg Oncol 35
J Clin Oncol 25
Cancer 22

Best Journals

N Engl J Med 4
J Clin Oncol 3
Ann Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Perioperative chemotherapy for clinical stage IIIB gallbladder cancer: a review of the National Cancer Database.
PMID 42209933 — gallbladder, lymph node excision, neoplasms, drug therapy, gallbladder neoplasms, therapeutics, chemotherapy		Int J Clin Oncol20260
MORPHology and Inter-observer Variation in Peritoneal Disease Assessment Among Expert Peritoneal Malignancy SUrgeonS: The MORPHEUS study.
PMID 41807839 — observer variation, neoplasms, peritoneal diseases, surgeons		Ann Surg Oncol20261
Thromboprophylaxis, pain and organization: How do expert centers manage PIPAC's perioperative care? An international survey.
PMID 42143535 — pain, perioperative care, biological monitoring, environmental monitoring, pressurized intraperitoneal aerosol chemotherapy		Eur J Surg Oncol20260
ASO Visual Abstract: Next-Generation Sequencing Identifies Key Targetable Mutations in the Treatment of Appendiceal Neoplasms.
PMID 42104035 — appendiceal neoplasms, high-throughput nucleotide sequencing, neoplasms, therapeutics, mutation		Ann Surg Oncol20260
ASO Visual Abstract: MORPHology and Inter-Observer Variation in Peritoneal Disease Assessment Among Expert Peritoneal Malignancy SUrgeonS-The MORPHEUS Study.
PMID 41920418 — observer variation, neoplasms, peritoneal diseases, surgeons		Ann Surg Oncol20260

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4 Study Chair: 2

By phase:

Phase 3 5
N/A 4
Phase 2 2
Phase 2/Phase 3 1

By status:

Completed 7
Recruiting 2
Active not recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 9
Observational 3

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 1
multicentric5to9 0
multicentricup10 6

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
NCT07001748 — anesthesia, general, research design, anesthesia, guidelines as topic, saline solution, absenteeism, paclitaxel, cicatrix, tomography, diffusion magnetic resonance imaging, esophagogastric junction, surgical procedures, operative, practice guidelines as topic, neoplasms, adenocarcinoma, magnetic resonance imaging, biopsy, laparoscopy, drug therapy, cell biology, appendix, specimen handling, peritoneal neoplasms, cost of illness, therapeutics, tissues, random allocation, peritoneal diseases, veins, stomach neoplasms, plasma, surgeons, chemotherapy, cytology		Phase 2/Phase 3Recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS